LITAF and exocrine pancreatic carcinoma: To investigate if promoter methylation might be responsible for the downregulation of LITAF, we examined the methylation status of the promoter region of LITAF by using MSP and BSP in the four pancreatic carcinoma cell lines and 25 paired pancreatic cancer samples.